A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies
Evan J. Wuthrick, Mitchell Kamrava, Walter J. Curran, Maria Werner-Wasik, Kevin A. Camphausen, Terry Hyslop, Rita Axelrod, David W. Andrews, Jon Glass, Mitchell MacHtay, Adam P. Dicker
Dive into the research topics of 'A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies'. Together they form a unique fingerprint.